Código QR (código de barras bidimensional)

The Risk of <i>Clostridioides difficile</i> Recurrence after Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health Facts

(1) Background: Fidaxomicin has been shown to significantly reduce <i>Clostridioides difficile</i> infection (CDI) recurrences rates in randomized, controlled trials. However, national data from the Veterans Affairs has called the real-world applicability of these findings into question. Therefore,...

Fuld beskrivelse

Na minha lista:
Principais autores: Ronald G. Hall, Travis J. Cole, Chip Shaw, Carlos A. Alvarez
Format: Artigo
Sprog:Inglês
Udgivet: MDPI AG 2022-02-01
Serier:Antibiotics
Fag:
fidaxomicin
vancomycin
<i>Clostridioides difficile</i>
CDI
recurrence
Online adgang:https://www.mdpi.com/2079-6382/11/3/295
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker